Canada warns about drug mix-up caused by similar names

11/9/2011 | CBC.ca (Canada)

Health Canada said five cases have been reported this year involving a drug mix-up of Pradax, by Boehringer Ingelheim, and Plavix, by Sanofi and Bristol-Myers Squibb, because of their similar trade names. One case resulted in nonserious bleeding after a medical procedure. Taking one drug when the other is prescribed could increase the risk of bleeding, heart attack or blood clots, the health agency said.

View Full Article in:

CBC.ca (Canada)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA